raxibacumab

AssetAlso called Abthrax

Binds anthrax protective antigen, blocking toxin entry into host cells.

Stage
Approved
Modality
Antibody
Target
PRDX1
3
Indications
3
Trials
2
Developers

Approved by the FDA on Dec 14, 2012 (BLA125349). FDA

Indications

3

In the full profile

  • Target and mechanism1
  • Owner and partners2
  • Trials3
  • Evidence for its targets1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets